Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Paediatric Respiratory Reviews|March 1, 2022
Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?Thomas Abrehart, Randy Suryadinata, Conor McCafferty, et al.
Vaccine|February 23, 2024
Audiovestibular adverse events following COVID-19 vaccinationsAishwarya N Shetty, Hannah J Morgan, Linny K Phuong, et al.
Plos One|June 3, 2022
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccinesPaola Villanueva, Ushma Wadia, Nigel W Crawford, et al.
Vaccine|September 21, 2024
Detailed review of mortality reported following COVID-19 vaccination in Victoria, Australia: 2021-2023Ingrid Laemmle-Ruff, Jesse J Fryk, Priya Shenton, et al.
Vaccine|December 28, 2023
Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance studyPriya Shenton, Silja Schrader, Julia Smith, et al.
Journal of Paediatrics and Child Health|February 19, 2019
Paediatric use of antibiotics in children with community acquired pneumonia: A survey from Da Nang, VietnamPhuong Tk Nguyen, Hoang T Tran, Huong Tt Truong, et al.
BMJ Paediatrics Open|September 2, 2022
Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12-17-year olds in Victoria, AustraliaDaryl R Cheng, Hazel J Clothier, Hannah J Morgan, et al.
Communicable Diseases Intelligence (2018)|February 16, 2022
The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in AustraliaNatasha K Brusco, Annette Alafaci, Jane Tuckerman, et al.
Communicable Diseases Intelligence (2018)|June 16, 2020
Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditionsJocelynne E McRae, Helen E Quinn, Gemma L Saravanos, et al.
Vaccine|November 10, 2021
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, AustraliaSally F Gordon, Hazel J Clothier, Hannah Morgan, et al.
Pageof 14